Nasopharyngeal carcinoma (NPC) is a rare type of head and neck cancer, with a higher incidence reported only in Southeast Asia and Northern Africa. Owing to the rarity of NPC occurrence, no internationally accepted consensus or guideline for its diagnosis and treatment is available. Based on the current evidences and practices, the Chinese experts on multidisciplinary diagnosis and treatment of NPC were designated to develop a national consensus for the treatment strategy of NPC. In this consensus, we report the development for improving the treatment efficacy and quality of life of NPC patients in China. The consensus also describes and recommends the role of multidisciplinary management approach in the management of NPC. A multidisciplinary team should include experts from different domains who can cater to the individualized needs of patients with NPC in a much more efficient manner. In addition, the team may also play a key role in developing guiding principles for future research, contributing to the improvement in the management of NPC.
[1]Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med,Dept Radiat Oncol, Chengdu, Sichuan, Peoples R China;
[2]Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China;
[3]Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol, State Key Lab Oncol Southern China,Canc Ctr, Guangzhou, Guangdong, Peoples R China;
[4]Fujian Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian, Peoples R China;
[5]Fujian Med Univ, Canc Hosp, Fuzhou, Fujian, Peoples R China;
[6]Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China;
[7]Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China
(8.0+极速模式)